Members of the Childrens Cancer Study Group treated 234 eligible patients in a randomized trial designed to study the relative effectiveness of two therapy programs for the treatment of childhood and adolescent non-Hodgkin's lymphoma. Two chemotherapeutic strategies were compared: a 4-drug regimen (COMP) and a 10-drug regimen (modified LSA2-L2). Failure-free survival for all patients was 60 per cent at 24 months. In patients with disseminated disease treatment success was influenced by both the histologic subtype of disease and the therapeutic regimen followed. The 10-drug program was more effective than the 4-drug program in patients with disseminated lymphoblastic disease (two-year failure-free survival rate, 76 vs. 26 per cent, respectively; P = 0.0002), whereas the 4-drug program was more effective than the 10-drug program in those with nonlymphoblastic disease (57 vs. 28 per cent, respectively, P = 0.008). The less toxic, more easily administered 4-drug regimen was as effective as the 10-drug regimen in patients with localized disease (89 vs. 84 per cent, respectively).
This article has been cited by other articles:
Bluhm, E. C., Ronckers, C., Hayashi, R. J., Neglia, J. P., Mertens, A. C., Stovall, M., Meadows, A. T., Mitby, P. A., Whitton, J. A., Hammond, S., Barker, J. D., Donaldson, S. S., Robison, L. L., Inskip, P. D.
(2008). Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Blood
111: 4014-4021
[Abstract][Full Text]
Salzburg, J., Burkhardt, B., Zimmermann, M., Wachowski, O., Woessmann, W., Oschlies, I., Klapper, W., Wacker, H.-H., Ludwig, W.-D., Niggli, F., Mann, G., Gadner, H., Riehm, H., Schrappe, M., Reiter, A.
(2007). Prevalence, Clinical Pattern, and Outcome of CNS Involvement in Childhood and Adolescent Non-Hodgkin's Lymphoma Differ by Non-Hodgkin's Lymphoma Subtype: A Berlin-Frankfurt-Munster Group Report. JCO
25: 3915-3922
[Abstract][Full Text]
Glotzbecker, M. P., Kersun, L. S., Choi, J. K., Wills, B. P., Schaffer, A. A., Dormans, J. P.
(2006). Primary Non-Hodgkin's Lymphoma of Bone in Children. JBJS
88: 583-594
[Abstract][Full Text]
Lones, M. A., Perkins, S. L., Sposto, R., Tedeschi, N., Kadin, M. E., Kjeldsberg, C. R., Wilson, J. F., Zwick, D. L., Cairo, M. S.
(2002). Non-Hodgkin's Lymphoma Arising in Bone in Children and Adolescents Is Associated With an Excellent Outcome: A Children's Cancer Group Report. JCO
20: 2293-2301
[Abstract][Full Text]
Kobrinsky, N. L., Sposto, R., Shah, N. R., Anderson, J. R., DeLaat, C., Morse, M., Warkentin, P., Gilchrist, G. S., Cohen, M. D., Shina, D., Meadows, A. T.
(2001). Outcomes of Treatment of Children and Adolescents With Recurrent Non-Hodgkin's Lymphoma and Hodgkin's Disease With Dexamethasone, Etoposide, Cisplatin, Cytarabine, and L-Asparaginase, Maintenance Chemotherapy, and Transplantation: Children's Cancer Group Study CCG-5912. JCO
19: 2390-2396
[Abstract][Full Text]
Moertel, C. L., Carlson-Green, B., Watterson, J., Simonton, S. C.
(2001). Lymphomatoid Granulomatosis After Childhood Acute Lymphoblastic Leukemia: Report of Effective Therapy. Pediatrics
107: 82e-82
[Abstract][Full Text]
Gaynon, P. S., Bostrom, B. C., Hutchinson, R. J., Lange, B. J., Nachman, J. B., Steinherz, P. G., Sensel, M. G., Lee, M. K., Stram, D. O., Sather, H. N.
(2001). Duration of Hospitalization as a Measure of Cost on Children's Cancer Group Acute Lymphoblastic Leukemia Studies. JCO
19: 1916-1925
[Abstract][Full Text]
Lones, M. A., Perkins, S. L., Sposto, R., Kadin, M. E., Kjeldsberg, C. R., Wilson, J. F., Cairo, M. S.
(2000). Large-Cell Lymphoma Arising in the Mediastinum in Children and Adolescents Is Associated With an Excellent Outcome: A Children's Cancer Group Report. JCO
18: 3845-3853
[Abstract][Full Text]
Gururangan, S., Sposto, R., Cairo, M. S., Meadows, A. T., Finlay, J. L.
(2000). Outcome Of CNS Disease At Diagnosis in Disseminated Small Noncleaved-Cell Lymphoma and B-Cell Leukemia: A Children's Cancer Group Study. JCO
18: 2017-2025
[Abstract][Full Text]
Reiter, A., Schrappe, M., Ludwig, W.-D., Tiemann, M., Parwaresch, R., Zimmermann, M., Schirg, E., Henze, G., Schellong, G., Gadner, H., Riehm, H.
(2000). Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM Group report. Blood
95: 416-421
[Abstract][Full Text]
Imashuku, S., Hibi, S., Ohara, T., Iwai, A., Sako, M., Kato, M., Arakawa, H., Sotomatsu, M., Kataoka, S., Asami, K., Hasegawa, D., Kosaka, Y., Sano, K., Igarashi, N., Maruhashi, K., Ichimi, R., Kawasaki, H., Maeda, N., Tanizawa, A., Arai, K., Abe, T., Hisakawa, H., Miyashita, H., Henter, J.-I.
(1999). Effective Control of Epstein-Barr Virus-Related Hemophagocytic Lymphohistiocytosis With Immunochemotherapy. Blood
93: 1869-1874
[Abstract][Full Text]
Suryanarayan, K., Shuster, J. J., Donaldson, S. S., Hutchison, R. E., Murphy, S. B., Link, M. P.
(1999). Treatment of Localized Primary Non-Hodgkin's Lymphoma of Bone in Children: A Pediatric Oncology Group Study. JCO
17: 456-456
[Abstract][Full Text]
Ladenstein, R., Pearce, R., Hartmann, O., Patte, C., Goldstone, T., Philip, T.
(1997). High-Dose Chemotherapy With Autologous Bone Marrow Rescue in Children With Poor-Risk Burkitt's Lymphoma: A Report From the European Lymphoma Bone Marrow Transplantation Registry. Blood
90: 2921-2930
[Abstract][Full Text]
Sandlund, J. T., Downing, J. R., Crist, W. M.
(1996). Non-Hodgkin's Lymphoma in Childhood. NEJM
334: 1238-1248
[Full Text]
Armitage, J. O.
(1993). Treatment of Non-Hodgkin's Lymphoma. NEJM
328: 1023-1030
[Full Text]
Previous
